phase i study of pevonedistat and ibrutinib in r/r b-nhl
Published 1 year ago • 48 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:04
phase i/ii study of a novel bet inhibitor, bms-986158, alone & with ruxolitinib or fedratinib in mf
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
38:23
managing pv - dr. richard silver
-
7:26
pirtobrutinib and prior bcl2 inhibitor exposure in cll - ash 2023 dr. jennifer woyach
-
56:57
hematopathology: flow cytometry and acute leukemias
-
2:43
phase i/ii trial of tagraxofusp in poor-risk myelofibrosis
-
1:52
phase i dose-escalation study of the bet inhibitor incb057643 in r/r myelofibrosis
-
3:46
overview of a phase i study of ono/gs-4059 in relapsed and refractory mature b-cell malignancies
-
1:17
hematopathology
-
2:03
preliminary results of a phase ii study of fedratinib in patients with mds/mpn and cnl
-
13:09
provincial blood coordinating office - ichip patient home module instructional video
-
2:04
design and results of persist-1 trial of pacritinib for myelofibrosis
-
4:48
an insight into the management of cytopenias in mf
-
3:31
know your caprini score!
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials